Literature DB >> 22579125

Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000.

Li Liu1, Hope L Johnson, Simon Cousens, Jamie Perin, Susana Scott, Joy E Lawn, Igor Rudan, Harry Campbell, Richard Cibulskis, Mengying Li, Colin Mathers, Robert E Black.   

Abstract

BACKGROUND: Information about the distribution of causes of and time trends for child mortality should be periodically updated. We report the latest estimates of causes of child mortality in 2010 with time trends since 2000.
METHODS: Updated total numbers of deaths in children aged 0-27 days and 1-59 months were applied to the corresponding country-specific distribution of deaths by cause. We did the following to derive the number of deaths in children aged 1-59 months: we used vital registration data for countries with an adequate vital registration system; we applied a multinomial logistic regression model to vital registration data for low-mortality countries without adequate vital registration; we used a similar multinomial logistic regression with verbal autopsy data for high-mortality countries; for India and China, we developed national models. We aggregated country results to generate regional and global estimates.
FINDINGS: Of 7·6 million deaths in children younger than 5 years in 2010, 64·0% (4·879 million) were attributable to infectious causes and 40·3% (3·072 million) occurred in neonates. Preterm birth complications (14·1%; 1·078 million, uncertainty range [UR] 0·916-1·325), intrapartum-related complications (9·4%; 0·717 million, 0·610-0·876), and sepsis or meningitis (5·2%; 0·393 million, 0·252-0·552) were the leading causes of neonatal death. In older children, pneumonia (14·1%; 1·071 million, 0·977-1·176), diarrhoea (9·9%; 0·751 million, 0·538-1·031), and malaria (7·4%; 0·564 million, 0·432-0·709) claimed the most lives. Despite tremendous efforts to identify relevant data, the causes of only 2·7% (0·205 million) of deaths in children younger than 5 years were medically certified in 2010. Between 2000 and 2010, the global burden of deaths in children younger than 5 years decreased by 2 million, of which pneumonia, measles, and diarrhoea contributed the most to the overall reduction (0·451 million [0·339-0·547], 0·363 million [0·283-0·419], and 0·359 million [0·215-0·476], respectively). However, only tetanus, measles, AIDS, and malaria (in Africa) decreased at an annual rate sufficient to attain the Millennium Development Goal 4.
INTERPRETATION: Child survival strategies should direct resources toward the leading causes of child mortality, with attention focusing on infectious and neonatal causes. More rapid decreases from 2010-15 will need accelerated reduction for the most common causes of death, notably pneumonia and preterm birth complications. Continued efforts to gather high-quality data and enhance estimation methods are essential for the improvement of future estimates. FUNDING: The Bill & Melinda Gates Foundation.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22579125     DOI: 10.1016/S0140-6736(12)60560-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  1401 in total

1.  Short-term outcomes after perinatal hypoxic ischemic encephalopathy: a report from the Children's Hospitals Neonatal Consortium HIE focus group.

Authors:  A N Massaro; K Murthy; I Zaniletti; N Cook; R DiGeronimo; M Dizon; S E G Hamrick; V J McKay; G Natarajan; R Rao; D Smith; R Telesco; R Wadhawan; J M Asselin; D J Durand; J R Evans; F Dykes; K M Reber; M A Padula; E K Pallotto; B L Short; A M Mathur
Journal:  J Perinatol       Date:  2014-11-13       Impact factor: 2.521

2.  Pneumonia's second wind? A case study of the global health network for childhood pneumonia.

Authors:  David Berlan
Journal:  Health Policy Plan       Date:  2015-10-05       Impact factor: 3.344

3.  Child pneumonia: beyond pneumococcal vaccine and 2015.

Authors:  T Duke; P M Enarson; S M Graham
Journal:  Public Health Action       Date:  2012-09-21

Review 4.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

5.  Diagnostic tools for tackling febrile illness and enhancing patient management.

Authors:  Konstantinos Mitsakakis; Valérie D'Acremont; Sebastian Hin; Felix von Stetten; Roland Zengerle
Journal:  Microelectron Eng       Date:  2018-10-05       Impact factor: 2.523

Review 6.  Climate Change Impacts on Waterborne Diseases: Moving Toward Designing Interventions.

Authors:  Karen Levy; Shanon M Smith; Elizabeth J Carlton
Journal:  Curr Environ Health Rep       Date:  2018-06

7.  Global childhood unintentional injury study: multisite surveillance data.

Authors:  Siran He; Jeffrey C Lunnen; Prasanthi Puvanachandra; Nukhba Zia; Adnan A Hyder
Journal:  Am J Public Health       Date:  2014-01-16       Impact factor: 9.308

Review 8.  Human diarrhea infections associated with domestic animal husbandry: a systematic review and meta-analysis.

Authors:  Laura D Zambrano; Karen Levy; Neia P Menezes; Matthew C Freeman
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-05-07       Impact factor: 2.184

9.  Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children.

Authors:  Elisabeth Dowling Root; Marilla Lucero; Hanna Nohynek; Peter Anthamatten; Deborah S K Thomas; Veronica Tallo; Antti Tanskanen; Beatriz P Quiambao; Taneli Puumalainen; Socorro P Lupisan; Petri Ruutu; Erma Ladesma; Gail M Williams; Ian Riley; Eric A F Simões
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

Review 10.  Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics.

Authors:  Ryan M McAdams; Sandra E Juul
Journal:  Clin Perinatol       Date:  2016-06-22       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.